Immunizations are an essential component of disease prevention and control. Preventing healthcare-associated transmission of infectious diseases protects patients, HCPs, their families, and their communities.
Through its many strategic partnerships, NFID works with a wide range of organizations to reduce the burden of infectious diseases in the US and amplify important messaging with ‘one strong voice.’
Parents usually rely on their child’s pediatrician to keep them up-to-date on vaccines. But the updated meningococcal vaccine recommendation recently issued by the Centers for Disease Control and Prevention (CDC) is different. The new recommendation paves the way for adolescents and young adults to get vaccinated against a rare, but deadly infection called serogroup B meningococcal disease–but it puts more responsibility on parents to seek and request the vaccine.
The independent and multi-layered vaccine review process can be complicated but is in place to ensure that vaccines are held to the highest standards of safety. Moreover, continuous monitoring of health problems after vaccination ensures that the US has a safe and effective vaccine supply.
Immunization is one of the 10 great public health successes of the 20th century. Through the use of vaccines, measles and rubella have been eliminated in the western hemisphere, polio has been eliminated from most of the world, and smallpox has been completely eradicated. However, while childhood vaccination rates are relatively high in the US, adult vaccination rates remain low.
The permissive (Category B) recommendation for meningococcal serogroup B vaccination reflects the science of the disease, takes into account many practical issues in vaccine delivery, and offers the widest range of solutions for patients and their families, healthcare providers, and the healthcare system.
While 44 states currently allow pharmacists to administer vaccines recommended by the Advisory Council on Immunization Practices (ACIP) and all 50 states allow influenza vaccines to be given, many states place barriers between patients and pharmacists as immunizers, primarily by age and/or prescription restrictions.
Adding a vaccine to the recommended schedule is not without controversy. All vaccines cost money—the meningococcal B vaccine costs around $130 a dose and currently the two vaccines available are part of a 2- or 3-dose series. However, the benefits of vaccination far out weigh the cost of vaccination.
Immunization apps can be a valuable tool to ensure you are referencing the most up-to-date immunization recommendations to patients.
2014 featured much activity in the world of infectious diseases–from the Ebola virus outbreak in West Africa, to increasing vaccine-preventable disease outbreaks here in the US. Featured below are the top 5 infectious diseases stories of the year, according to NFID. While the list is by no means exhaustive, it highlights several significant developments in infectious disease prevention and the ongoing importance of vaccination….
Find out what you might have missed at the February 2014 ACIP meeting held this week.
There is still much work to be done to increase adult vaccination rates in the United States to reach public health goals. William Schaffner, MD, NFID immediate past-president, wrote the post below for Infectious Disease News on the importance of every patient medical visit representing an opportunity to vaccinate. Despite well-documented evidence regarding effectiveness and safety, overall adult vaccination rates in the…